Trials / Completed
CompletedNCT04080193
Gender-sensitive Enhancement of Common Weight Loss Strategies for Overweight and Obesity
Gender-sensitive Enhancement of Common Weight Loss Strategies for Overweight and Obesity: a Personalized Smartphone App
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 213 (actual)
- Sponsor
- Otto-Friedrich-University Bamberg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The major aim of the proposed study is to develop a gender-sensitive individually tailored add-on intervention that focusses on improving individual gender-specific SIRs (subjective illness representations) in obese or overweight individuals. We will investigate whether this will improve compliance with and long-term success of common weight loss interventions. The effectiveness of this intervention in every-day-life with regard to weight-related behavioral changes and weight loss will be evaluated within a randomized controlled setting.To enhance the applicability of the intervention in every-day-life and its dissemination we plan to develop a smart-phone-based intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Smartphone-based interventional trial | According to the SIRs the 12-week intervention will contain exercises from three out of six different key modules (e.g. self-efficacy, impulsivity). The remaining modules will be implemented as mini-modules during the end of the intervention phase. The study will be designed gender-sensitive instead of gender-dichotomous. This means that treatment contents will be individualized based on gender-related SIRs and not biological sex. Participants choose between two different styles of presentation for each module and the contents can be deepened within specific exercises. |
Timeline
- Start date
- 2019-12-07
- Primary completion
- 2021-12-22
- Completion
- 2022-02-28
- First posted
- 2019-09-06
- Last updated
- 2022-05-09
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04080193. Inclusion in this directory is not an endorsement.